Preoperative breast MRI and surgical outcomes in elderly women with invasive ductal and lobular carcinoma: A population-based study

Breast Cancer Research and Treatment

Volumn 143, Issue 1, 2014, Pages 203-212

  Fortune Greeley, Alice K ^a   Wheeler, Stephanie B ^a,b   Meyer, Anne Marie ^a,b   Reeder Hayes, Katherine E ^b,c   Biddle, Andrea K ^a   Muss, Hyman B ^b,c   Carpenter, William R ^a,b  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Invasive lobular carcinoma; Magnetic resonance imaging; Preoperative care; SEER medicare; Surgery, outcomes

Indexed keywords

AGED; ARTICLE; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER INCIDENCE; COHORT ANALYSIS; CONTROLLED STUDY; EARLY CANCER; EDUCATIONAL STATUS; ELDERLY CARE; FEMALE; FINAL MASTECTOMY; HEALTH CARE PLANNING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICARE; MIXED DUCTAL LOBULAR CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROPENSITY SCORE; REOPERATION; RETROSPECTIVE STUDY; SCORING SYSTEM; SURGICAL TECHNIQUE; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MASTECTOMY; NEOPLASM GRADING; NEOPLASM STAGING; ODDS RATIO; PREOPERATIVE CARE; RETREATMENT; RETROSPECTIVE STUDIES; RISK FACTORS; SEER PROGRAM; TREATMENT OUTCOME;

EID: 84892807001     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2787-4     Document Type: Article

References (54)

1. Sommer CA, Stitzenberg KB, Tolleson-Rinehart S, Carpenter WR, Carey TS (2011) Breast MRI utilization in older patients with newly diagnosed breast cancer. J Surg Res 170(1):77-83
2. Wang SY, Virnig BA, Tuttle TM, Jacobs DR, Kuntz KM, Kane RL (2013) Variability of preoperative breast MRI utilization among older women with newly diagnosed early-stage breast cancer. Breast J 19(6):627-636
3. Killelea BK, Lannin DR, Horvath LJ, Horowitz NR, Chagpar AB (2013) Factors associated with breast MRI use: a population-based analysis. Ann Surg Oncol 20(6):1798-1805
4. Killelea BK, Long JB, Chagpar AB, Ma X, Soulos PR, Ross JS, Gross CP (2013) Trends and clinical implications of preoperative breast MRI in medicare beneficiaries with breast cancer. Breast Cancer Res Treat 141(1):155-163
5. Turnbull L, Brown S, Harvey I, Olivier C, Drew P, Napp V, Hanby A, Brown J (2010) Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 375(9714):563-571
6. Peters NH, van Esser S, van den Bosch MA, Storm RK, Plaisier PW, van Dalen T, Diepstraten SC, Weits T, Westenend PJ, Stapper G et al (2011) Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET: randomised controlled trial. Eur J Cancer 47(6):879-886
7. Wang S-Y, Kuntz KM, Tuttle TM, Jacobs Jr DR, Kane RL, Virnig BA: The association of preoperative breast magnetic resonance imaging and multiple breast surgeries among older women with early stage breast cancer. Breast Cancer Res Treat 2013
8. Houssami N, Turner R, Morrow M (2013) Preoperative magnetic resonance imaging in breast cancer: meta-analysis of surgical outcomes. Ann Surg 257(2):249-255
9. Li CI, Anderson BO, Daling JR, Moe RE (2003) Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 289(11):1421-1424
10. Sardanelli F (2010) Overview of the role of pre-operative breast MRI in the absence of evidence on patient outcomes. Breast 19(1):3-6
11. Krecke KN, Gisvold J (1993) Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients. Am J Roentgenol 161(5):957-960
12. Yeatman TJ, Cantor AB, Smith TJ, Smith SK, Reintgen DS, Miller MS, Ku NN, Baekey PA, Cox CE (1995) Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg 222(4):549-559 discussion 559-561
13. Silverstein MJ, Lewinsky BS, Waisman JR, Gierson ED, Colburn WJ, Senofsky GM, Gamagami P (2006) Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer 73(6):1673-1677
14. Waljee JF, Hu ES, Newman LA, Alderman AK (2008) Predictors of re-excision among women undergoing breast-conserving surgery for cancer. Ann Surg Oncol 15(5):1297-1303
15. Keskek M, Kothari M, Ardehali B, Betambeau N, Nasiri N, Gui G (2004) Factors predisposing to cavity margin positivity following conservation surgery for breast cancer. Eur J Surg Oncol 30(10):1058-1064
16. Van den Broek N, van der Sangen MJC, Van de Poll-Franse L, van Beek MWPM, Nieuwenhuijzen GAP, Voogd A (2007) Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer. Breast Cancer Res Treat 105(1):63-68
17. Mann RM, Hoogeveen YL, Blickman JG, Boetes C (2008) MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature. Breast Cancer Res Treat 107(1):1-14
18. Heil J, Bühler A, Golatta M, Rom J, Harcos A, Schipp A, Rauch G, Junkermann H, Sohn C (2011) Does a supplementary preoperative breast MRI in patients with invasive lobular breast cancer change primary and secondary surgical interventions? Ann Surg Oncol 18(8):2143-2149
19. Mann RM, Loo CE, Wobbes T, Bult P, Barentsz JO, Gilhuijs KGA, Boetes C (2010) The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast. Breast Cancer Res Treat 119(2):415-422
20. McGhan LJ, Wasif N, Gray RJ, Giurescu ME, Pizzitola VJ, Lorans R, Ocal IT, Stucky CCH, Pockaj BA (2010) Use of preoperative magnetic resonance imaging for invasive lobular cancer: good, better, but maybe not the best? Ann Surg Oncol 17:255-262
21. Warren JL, Harlan LC, Fahey A, Virnig BA, Freeman JL, Klabunde CN, Cooper GS, Knopf KB (2002) Utility of the SEER-medicare data to identify chemotherapy use. Med Care 40(8):IV-55-61
22. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40(8 Suppl):3-18
23. Croshaw R, Shapiro-Wright H, Svensson E, Erb K, Julian T (2011) Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients. Ann Surg Oncol 18(11):3160-3163
24. McGuire KP, Toro-Burguete J, Dang H, Young J, Soran A, Zuley M, Bhargava R, Bonaventura M, Johnson R, Ahrendt G (2011) MRI staging after neoadjuvant chemotherapy for breast cancer: does tumor biology affect accuracy? Ann Surg Oncol 18(11):3149-3154
25. Chen JH, Feig B, Agrawal G, Yu H, Carpenter PM, Mehta RS, Nalcioglu O, Su MY (2008) MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy. Cancer 112(1):17-26
26. Marinovich ML, Sardanelli F, Ciatto S, Mamounas E, Brennan M, Macaskill P, Irwig L, von Minckwitz G, Houssami N (2012) Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI. Breast 21(5):669-677
27. Lobbes MB (2012) Treatment response evaluation by MRI in breast cancer patients receiving neoadjuvant chemotherapy: there is more than just pathologic complete response prediction. Breast Cancer Res Treat 136(1):313-314
28. NCCN Clinical Practice Guidelines in Oncology: Breast cancer screening and diagnosis (nccn.org)
29. Earle CC, Nattinger AB, Potosky AL, Lang K, Mallick R, Berger M, Warren JL (2002) Identifying cancer relapse using SEER-medicare data. Med Care 40(8):IV-75-81
30. Cheng L, Swartz MD, Zhao H, Kapadia AS, Lai D, Rowan PJ, Buchholz TA, Giordano SH (2012) Hazard of recurrence among women after primary breast cancer treatment: a 10-year follow-up using data from SEER-medicare. Cancer Epidemiol Biomarkers Prev 21(5):800-809
31. Friese CR, Neville BA, Edge SB, Hassett MJ, Earle CC (2009) Breast biopsy patterns and outcomes in surveillance, epidemiology, and end results: medicare data. Cancer 115(4):716-724
32. Gutwein LG, Ang DN, Liu H, Marshall JK, Hochwald SN, Copeland EM, Grobmyer SR (2011) Utilization of minimally invasive breast biopsy for the evaluation of suspicious breast lesions. Am J Surg 202(2):127-132
33. Mandelblatt JS, Hadley J, Kerner JF, Schulman KA, Gold K, Dunmore-Griffith J, Edge S, Guadagnoli E, Lynch JJ, Meropol NJ et al (2000) Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influences. Cancer 89(3):561-573
34. McCahill LE, Single RM, Aiello Bowles EJ, Feigelson HS, James TA, Barney T, Engel JM, Onitilo AA (2012) Variability in reexcision following breast conservation surgery. JAMA 307(5):467-475
35. Klabunde CN, Legler JM, Warren JL, Baldwin LM, Schrag D (2007) A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol 17(8):584-590
36. Carpenter WR, Reeder-Hayes K, Bainbridge J, Meyer A-M, Amos KD, Weiner BJ, Godley PA (2011) The role of organizational affiliations and research networks in the diffusion of breast cancer treatment innovation. Med Care 49(2):172-179
37. Rosenbaum P (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70:41-55
38. Sato T, Matsuyama Y (2003) Marginal structural models as a tool for standardization. Epidemiology 14(6):680-686
39. Stuart EA (2010) Matching methods for causal inference: a review and a look forward. Stat Sci 25(1):1-21
40. Austin PC (2008) A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med 27(12):2037-2049
41. Houssami N, Ciatto S, Macaskill P, Lord SJ, Warren RM, Dixon JM, Irwig L (2008) Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 26(19):3248-3258
42. Plana MN, Carreira C, Muriel A, Chiva M, Abraira V, Emparanza JI, Bonfill X, Zamora J (2012) Magnetic resonance imaging in the preoperative assessment of patients with primary breast cancer: systematic review of diagnostic accuracy and meta-analysis. Eur Radiol 22(1):26-38
43. Pengel KE, Loo CE, Teertstra HJ, Muller SH, Wesseling J, Peterse JL, Bartelink H, Rutgers EJ, Gilhuijs KGA (2009) The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study. Breast Cancer Res Treat 116(1):161-169
44. Bleicher RJ, Ciocca RM, Egleston BL, Sesa L, Evers K, Sigurdson ER, Morrow M (2009) Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg 209(2):180-187
45. Miller BT, Abbott AM, Tuttle TM (2012) The influence of preoperative MRI on breast cancer treatment. Ann Surg Oncol 19(2):536-540
46. Hwang N, Schiller DE, Crystal P, Maki E, McCready DR (2009) Magnetic resonance imaging in the planning of initial lumpectomy for invasive breast carcinoma: its effect on ipsilateral breast tumor recurrence after breast-conservation therapy. Ann Surg Oncol 16(11):3000-3009
47. Shin HC, Han W, Moon HG, Yom CK, Ahn SK, You JM, Kim JS, Chang JM, Cho N, Moon WK et al (2012) Limited value and utility of breast MRI in patients undergoing breast-conserving cancer surgery. Ann Surg Oncol 19(8):2572-2579
48. Morrow M (2010) Magnetic resonance imaging for screening, diagnosis, and eligibility for breast-conserving surgery: promises and pitfalls. Surg Oncol Clin N Am 19:475-492
49. Krishnan M, Thorsteinsson D, Horowitz N, Weinreb J, Lanin D, Lee C (2008) The influence of preoperative MRI in the timing and type of therapy in women newly diagnosed with breast cancer. Am J Roentgenol 190:A31-A34
50. Hulvat M, Sandalow N, Rademaker A, Helenowski I, Hansen NM (2010) Time from diagnosis to definitive operative treatment of operable breast cancer in the era of multimodal imaging. Surgery 148(4):746-751
51. Morrow M, Katz SJ (2012) The challenge of developing quality measures for breast cancer surgery. JAMA 307(5):509-510
52. O'Flynn EA, Currie RJ, Mohammed K, Allen SD, Michell MJ (2013) Pre-operative factors indicating risk of multiple operations versus a single operation in women undergoing surgery for screen detected breast cancer. Breast 22(1):78-82
53. Shin HC, Han W, Moon HG, Cho N, Moon WK, Park IA, Park SJ, Noh DY (2012) Nomogram for predicting positive resection margins after breast-conserving surgery. Breast Cancer Res Treat 134(3):1115-1123
54. Wilkinson L, Given-Wilson R, Hall T, Potts H, Sharma A, Smith E (2005) Increasing the diagnosis of multifocal primary breast cancer by the use of bilateral whole-breast ultrasound. Clin Radiol 60(5):573-578